| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* CBR Institute for Biomedical Research and Department of Pathology, Harvard University, Boston, MA 02115;
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; and
Department of Immunobiology, Boston University Medical Center, Boston, MA 02118
The adaptive immune response is tightly regulated to limit responding cells in an Ag-specific manner. On B cells, coreceptors CD21/CD19 modulate the strength of BCR signals, potentially influencing cell fate. The importance of the CD95 pathway was examined in response of B cells to moderate affinity Ag using an adoptive transfer model of lysozyme-specific Ig transgenic (HEL immunoglobulin transgene (MD4) strain) B cells. Although adoptively transferred Cr2+/+ MD4 B cells are activated and persist within splenic follicles of duck egg lysozyme-immunized mice, Cr2–/– MD4 B cells do not. In contrast, Cr2–/– MD4 lpr B cells persist after transfer, suggesting that lack of CD21/CD35 signaling results in CD95-mediated elimination. Cr2 deficiency did not affect CD95 levels, but cellular FLIP (c-FLIP) protein and mRNA levels were reduced 2-fold compared with levels in Cr2+/+ MD4 B cells. In vitro culture with Cr2+/+ MD4 B cells demonstrated that equimolar amounts of rHEL-C3d3 were more effective than hen egg lysozyme alone in up-regulating c-FLIP levels and for protection against CD95-mediated apoptosis. Collectively, this study implies a mechanism for regulating B cell survival in vivo whereby the strength of BCR signaling (including coreceptor) determines c-FLIP levels and protection from CD95-induced death.
This article has been cited by other articles:
|
|
 |
|
  R. A. Barrington, T. J. Schneider, L. A. Pitcher, T. R. Mempel, M. Ma, N. S. Barteneva, and M. C. Carroll Uncoupling CD21 and CD19 of the B-cell coreceptor PNAS, August 25, 2009; 106(34): 14490 - 14495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-I. Inoue, E. Koike, H. Takano, R. Yanagisawa, T. Ichinose, and T. Yoshikawa Effects of Diesel Exhaust Particles on Antigen-Presenting Cells and Antigen-Specific Th Immunity in Mice Experimental Biology and Medicine, February 1, 2009; 234(2): 200 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Jacobson and J. H. Weis Comparative Functional Evolution of Human and Mouse CR1 and CR2 J. Immunol., September 1, 2008; 181(5): 2953 - 2959. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Jacobson, J. J. Weis, and J. H. Weis Complement Receptors 1 and 2 Influence the Immune Environment in a B Cell Receptor-Independent Manner J. Immunol., April 1, 2008; 180(7): 5057 - 5066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. de Andres, I. Cortegano, N. Serrano, B. del Rio, P. Martin, P. Gonzalo, M. A. R. Marcos, and M. L. Gaspar A Population of CD19highCD45R /lowCD21low B Lymphocytes Poised for Spontaneous Secretion of IgG and IgA Antibodies J. Immunol., October 15, 2007; 179(8): 5326 - 5334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thomas, M. Calamito, B. Srivastava, I. Maillard, W. S. Pear, and D. Allman Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation Blood, April 15, 2007; 109(8): 3342 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. van Zelm, I. Reisli, M. van der Burg, D. Castano, C. J.M. van Noesel, M. J.D. van Tol, C. Woellner, B. Grimbacher, P. J. Patino, J. J.M. van Dongen, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med., May 4, 2006; 354(18): 1901 - 1912. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
